General Information of Drug Transporter (DT)
DT ID DTD0519 Transporter Info
Gene Name CACNA1B
Transporter Name Voltage-gated calcium channel alpha Cav2.2
Gene ID
774
UniProt ID
Q00975
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM)

Chemical Compound

  DT Modulation1

NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of CACNA1B mRNA [21]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Valproic Acid affects the expression of CACNA1B mRNA [32]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in decreased expression of CACNA1B mRNA [21]

Regulation Mechanism

Transcription Factor Info

  11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid which affects the methylation of CACNA1B gene [20]

Regulation Mechanism

Transcription Factor Info

  4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in decreased expression of CACNA1B mRNA [21]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of CACNA1B mRNA [21]

Regulation Mechanism

Transcription Factor Info

  Barium

         16 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

CACNA1B gene polymorphism affects the transport of Barium [22]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

CACNA1B protein results in increased transport of Barium [23]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Cadmium Chloride inhibits the reaction CACNA1B protein results in increased transport of Barium [24]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

GNB1 protein binds to GNG2 protein inhibits the reaction CACNA1B protein results in increased transport of Barium [23]

Regulation Mechanism

Transcription Factor Info

  DT Modulation5

GNB1 protein binds to GNG3 protein inhibits the reaction CACNA1B protein results in increased transport of Barium [23]

Regulation Mechanism

Transcription Factor Info

  DT Modulation6

GNB1 protein binds to GNGT1 protein inhibits the reaction CACNA1B protein results in increased transport of Barium [23]

Regulation Mechanism

Transcription Factor Info

  DT Modulation7

GNB2 protein binds to GNG2 protein inhibits the reaction CACNA1B protein results in increased transport of Barium [23]

Regulation Mechanism

Transcription Factor Info

  DT Modulation8

GNB2 protein binds to GNG3 protein inhibits the reaction CACNA1B protein results in increased transport of Barium [23]

Regulation Mechanism

Transcription Factor Info

  DT Modulation9

GNB2 protein binds to GNGT1 protein inhibits the reaction CACNA1B protein results in increased transport of Barium [23]

Regulation Mechanism

Transcription Factor Info

  DT Modulation10

GNB3 protein binds to GNG2 protein inhibits the reaction CACNA1B protein results in increased transport of Barium [23]

Regulation Mechanism

Transcription Factor Info

  DT Modulation11

GNB3 protein binds to GNG3 protein inhibits the reaction CACNA1B protein results in increased transport of Barium [23]

Regulation Mechanism

Transcription Factor Info

  DT Modulation12

GNB3 protein binds to GNGT1 protein inhibits the reaction CACNA1B protein results in increased transport of Barium [23]

Regulation Mechanism

Transcription Factor Info

  DT Modulation13

GNB4 protein binds to GNG2 protein inhibits the reaction CACNA1B protein results in increased transport of Barium [23]

Regulation Mechanism

Transcription Factor Info

  DT Modulation14

GNB4 protein binds to GNG3 protein inhibits the reaction CACNA1B protein results in increased transport of Barium [23]

Regulation Mechanism

Transcription Factor Info

  DT Modulation15

GNB4 protein binds to GNGT1 protein inhibits the reaction CACNA1B protein results in increased transport of Barium [23]

Regulation Mechanism

Transcription Factor Info

  DT Modulation16

GNB5 protein binds to GNG2 protein inhibits the reaction CACNA1B protein results in increased transport of Barium [23]

Regulation Mechanism

Transcription Factor Info

  Benzo(a)pyrene

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Benzo(a)pyrene results in increased methylation of CACNA1B promoter [25]

Regulation Mechanism

Transcription Factor Info

  bisphenol A

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

bisphenol A results in decreased methylation of CACNA1B gene [26]

Regulation Mechanism

Transcription Factor Info

  Cadmium Chloride

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Cadmium Chloride inhibits the reaction CACNA1B protein results in increased transport of Barium [24]

Regulation Mechanism

Transcription Factor Info

  Cannabinoids

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid which affects the methylation of CACNA1B gene [20]

Regulation Mechanism

Transcription Factor Info

  CGP 52608

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

CGP 52608 promotes the reaction RORA protein binds to CACNA1B gene [27]

Regulation Mechanism

Transcription Factor Info

  Cyclosporine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Cyclosporine results in decreased methylation of CACNA1B promoter [28]

Regulation Mechanism

Transcription Factor Info

  dorsomorphin

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in decreased expression of CACNA1B mRNA [21]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of CACNA1B mRNA [21]

Regulation Mechanism

Transcription Factor Info

  ethyl-p-hydroxybenzoate

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

ethyl-p-hydroxybenzoate results in decreased expression of CACNA1B mRNA [29]

Regulation Mechanism

Transcription Factor Info

  Methylcholanthrene

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Methylcholanthrene promotes the reaction AHR protein binds to CACNA1B promoter [30]

Regulation Mechanism

Transcription Factor Info

  propionaldehyde

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

propionaldehyde results in decreased expression of CACNA1B mRNA [31]

Regulation Mechanism

Transcription Factor Info

  sodium arsenite

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

sodium arsenite results in increased expression of CACNA1B mRNA [12]

Regulation Mechanism

Transcription Factor Info

  trichostatin A

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

trichostatin A results in increased expression of CACNA1B mRNA [10]

Regulation Mechanism

Transcription Factor Info

Approved Drug

  Clotrimazole

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Clotrimazole inhibits the activity of CACNA1B [3]

Cell System

SH-SY5Y neuroblastoma cells-CACNA1B

  Econazole

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Econazole inhibits the activity of CACNA1B [3]

Cell System

SH-SY5Y neuroblastoma cells-CACNA1B

  Miconazole

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Miconazole inhibits the activity of CACNA1B [3]

Cell System

SH-SY5Y neuroblastoma cells-CACNA1B

  Estradiol

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Estradiol increases the expression of CACNA1B [4]

  Menthol

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Menthol inhibits the expression of CACNA1B [5]

  Valproic Acid

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Valproic Acid increases the expression of CACNA1B [6]

  KB-2796

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Lomerizine inhibits the activity of CACNA1B [7]

  Hesperidin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Hesperidin inhibits the activity of CACNA1B [8]

Drug in Phase 3 Trial

  Triclosan

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Triclosan inhibits the expression of CACNA1B [13]

  Cilnidipine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Cilnidipine blocks the activity of CACNA1B [16], [17]

  Ralfinamide

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Ralfinamide blocks the activity of CACNA1B [19]

Drug in Phase 2 Trial

  CNV-2197944

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

CNV-2197944 blocks the activity of CACNA1B [18]

Drug in Phase 1 Trial

  Mibefradil

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Mibefradil inhibits the activity of CACNA1B [1], [2]

Cell System

Human embryonic kidney 293 cells (HEK293)-CACNA1B

  DT Modulation2

Mibefradil inhibits the activity of CACNA1B [3]

Cell System

SH-SY5Y neuroblastoma cells-CACNA1B

  Trichostatin A

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Trichostatin A increases the expression of CACNA1B [10]

  Sodium arsenite

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Sodium arsenite increases the expression of CACNA1B [12]

Investigative Drug

  Phenylmercuric Acetate

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Phenylmercuric Acetate inhibits the expression of CACNA1B [11]

  GNF-PF-3464

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

GNF-PF-3464 inhibits the activity of CACNA1B [8]

Natural Product

  Tobacco Smoke Pollution

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Tobacco Smoke Pollution inhibits the expression of CACNA1B [15]

Health and Environmental Toxicant

  Diethylhexyl Phthalate

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Diethylhexyl Phthalate inhibits the expression of CACNA1B [14]

Herbicide

  Atrazine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Atrazine increases the expression of CACNA1B [9]
References
1 Synthesis and biological activity of 3,4-dihydroquinazolines for selective T-type Ca2+ channel blockers. Bioorg Med Chem Lett. 2005 Jan 17;15(2):283-6.
2 Morpholin-2-one derivatives as novel selective T-type Ca2+ channel blockers. Bioorg Med Chem Lett. 2006 Oct 1;16(19):5244-8.
3 Evaluation of known and novel inhibitors of Orai1-mediated store operated Ca2+ entry in MDA-MB-231 breast cancer cells using a Fluorescence Imaging Plate Reader assay. Bioorg Med Chem. 2017 Jan 1;25(1):440-449.
4 Differential regulation of native estrogen receptor-regulatory elements by estradiol, tamoxifen, and raloxifene. Mol Endocrinol. 2008 Feb;22(2):287-303.
5 Repurposing L-Menthol for Systems Medicine and Cancer Therapeutics? L-Menthol Induces Apoptosis through Caspase 10 and by Suppressing HSP90. OMICS. 2016 Jan;20(1):53-64.
6 Stem Cell Transcriptome Responses and Corresponding Biomarkers That Indicate the Transition from Adaptive Responses to Cytotoxicity. Chem Res Toxicol. 2017 Apr 17;30(4):905-922.
7 Synthesis and SAR of novel 2-arylthiazolidinones as selective analgesic N-type calcium channel blockers. Bioorg Med Chem Lett. 2007 Feb 1;17(3):662-7.
8 In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2). Bioorg Med Chem Lett. 2010 Dec 15;20(24):7331-6.
9 Endoplasmic reticulum stress impairs insulin signaling through mitochondrial damage in SH-SY5Y cells. Neurosignals. 2012;20(4):265-80.
10 From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. Arch Toxicol. 2014 Jul;88(7):1451-68.
11 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.
12 Cellular and Molecular Effects of Prolonged Low-Level Sodium Arsenite Exposure on Human Hepatic HepaRG Cells. Toxicol Sci. 2018 Apr 1;162(2):676-687.
13 Transcriptome and DNA Methylome Dynamics during Triclosan-Induced Cardiomyocyte Differentiation Toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
14 Di-(2-ethylhexyl)-phthalate induces apoptosis via the PPAR Gamma/PTEN/AKT pathway in differentiated human embryonic stem cells. Food Chem Toxicol. 2019 Sep;131:110552.
15 Integration of transcriptome analysis with pathophysiological endpoints to evaluate cigarette smoke toxicity in an in vitro human airway tissue model. Arch Toxicol. 2021 May;95(5):1739-1761.
16 Pharmacology of N-type Ca2+ channels distributed in cardiovascular system (Review). Int J Mol Med. 1999 May;3(5):455-66.
17 N- and L-type calcium channel antagonist improves glomerular dynamics, reverses severe nephrosclerosis, and inhibits apoptosis and proliferation in an l-NAME/SHR model. J Hypertens. 2002 May;20(5):993-1000.
18 Clinical pipeline report, company report or official report of Convergence Pharmaceuticals Ltd.
19 Emerging drugs in neuropathic pain. Expert Opin Emerg Drugs. 2007 Mar;12(1):113-26.
20 Cannabinoid exposure and altered DNA methylation in rat and human sperm. Epigenetics. 2018;13(12):1208-1221.
21 Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests. Arch Toxicol. 2017 Feb;91(2):839-864.
22 Identification and characterization of novel human Ca(v)2.2 (alpha 1B) calcium channel variants lacking the synaptic protein interaction site. J Neurosci. 2002;22(1):82-92.
23 Selective regulation of N-type Ca channels by different combinations of G-protein beta/gamma subunits and RGS proteins. J Neurosci. 2000;20(19):7143-8.
24 Appearance of voltage-gated calcium channels following overexpression of ATPase II cDNA in neuronal HN2 cells. Brain Res Mol Brain Res. 2003;117(2):109-15.
25 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017;8(1):1369-1391.
26 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019;11(1):138.
27 Identification of potential target genes of ROR-alpha in THP1 and HUVEC cell lines. Exp Cell Res. 2017;353(1):6-15.
28 Integrative "-Omics" Analysis in Primary Human Hepatocytes Unravels Persistent Mechanisms of Cyclosporine A-Induced Cholestasis. Chem Res Toxicol. 2016 Dec 19;29(12):2164-2174.
29 Risk assessment of parabens in a transcriptomics-based in vitro test. Chem Biol Interact. 2023;384:110699.
30 3-methylcholanthrene induces differential recruitment of aryl hydrocarbon receptor to human promoters. Toxicol Sci. 2010;117(1):90-100.
31 Integrated analysis of microRNA and mRNA expression profiles highlights aldehyde-induced inflammatory responses in cells relevant for lung toxicity. Toxicology. 2015 Aug 6;334:111-21.
32 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20.

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.